ATAI Life Sciences N.V. - stock earnings
ATAI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 44.2 million USD | 87000 USD |
| 2023Q2 | -33.0 million USD | 172000 USD |
| 2023Q1 | -33.3 million USD | 37000 USD |
| 2022Q4 | -45.3 million USD | 38000 USD |
| 2022Q3 | -33.3 million USD | 24000 USD |
| 2022Q2 | -30.9 million USD | 170000 USD |
| 2022Q1 | -32.0 million USD | ? USD |
| 2021Q4 | -88.9 million USD | 230000 USD |
| 2021Q3 | -31.2 million USD | 266000 USD |
| 2021Q2 | -48.5 million USD | ? USD |
| 2021Q1 | 688000 USD | 19.9 million USD |
| 2020Q4 | -86.6 million USD | ? USD |
| 2020Q3 | -83.2 million USD | ? USD |
| 2020Q2 | -16.4 million USD | ? USD |
| 2020Q1 | 16.3 million USD | ? USD |
ATAI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -66.9 million USD | 334000 USD |
| 2022 | -141.4 million USD | 233000 USD |
| 2021 | -132.6 million USD | 20.4 million USD |
| 2020 | -102.1 million USD | 19.9 million USD |
| 2019 | -17.5 million USD | ? USD |
ATAI
Price: $2.05
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.43 USD
P/E Ratio: -4.16
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.5 million
Ebitda: 9.8 millionMarket Capitalization: 403.4 million
Average Dividend Frequency: 1